Cohen Klingenstein LLC Pfizer Inc Transaction History

Cohen Klingenstein LLC

$2.65 Billion
Q2 2024

A detailed history of Cohen Klingenstein LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cohen Klingenstein LLC holds 169,173 shares of PFE stock, worth $4.83 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

169,173

Previous 169,171 -0.0%

Holding current value

$4.83 Million

Previous $4.69 Million 0.83%

% of portfolio

0.18%

Previous 0.18%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $50 - $59	2 Added 0.0%	169,173 $4.73 Million
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $1,346 - $1,545	-52 Reduced 0.03%	169,171 $4.69 Million
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $52 - $67	2 Added 0.0%	169,223 $4.87 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $64 - $75	2 Added 0.0%	169,221 $5.61 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $72 - $83	2 Added 0.0%	169,219 $6.21 Million
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $78 - $102	2 Added 0.0%	169,217 $6.9 Million
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $8,391 - $10,954	201 Added 0.12%	169,215 $0
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $709,877 - $1.05 Million	-17,180 Reduced 9.23%	169,014 $9.98 Million
Q3 2021 Oct 15, 2021	BUY	$39.25 - $50.42 $7,653 - $9,831	195 Added 0.1%	186,194 $8.01 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $451,004 - $511,832	13,700 Added 7.95%	185,999 $7.29 Million
Q2 2019 Jul 15, 2019	BUY	$36.98 - $41.52 $2.64 Million - $2.96 Million	71,364 Added 70.7%	172,299 $7.46 Million
Q1 2019 Apr 16, 2019	BUY	$37.5 - $41.2 $559,200 - $614,374	14,912 Added 17.33%	100,935 $4.29 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $2.67 Million - $2.94 Million	86,023	86,023 $3.07 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.

Account

Cohen Klingenstein LLC Pfizer Inc Transaction History